APA
TEVA icon

American Portfolios Advisors’s Teva Pharmaceuticals TEVA Stock Holding History

American Portfolios Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$12.1K Sell
1,500
-481
-24% -$4.25K ﹤0.01% 2443
2022
Q2 		$14.9K Buy
1,981
+127
+7% +$1.11K ﹤0.01% 2375
2022
Q1 		$17.4K Hold
1,854
– – ﹤0.01% 2446
2021
Q4 		$14.9K Hold
1,854
– – ﹤0.01% 2451
2021
Q3 		$18.1K Buy
1,854
+597
+47% +$5.59K ﹤0.01% 2327
2021
Q2 		$12.4K Sell
1,257
-492
-28% -$5.21K ﹤0.01% 2408
2021
Q1 		$20.2K Buy
1,749
+473
+37% +$5.42K ﹤0.01% 2066
2020
Q4 		$12.3K Sell
1,276
-926
-42% -$8.87K ﹤0.01% 2018
2020
Q3 		$19.8K Sell
2,202
-442
-17% -$4.68K ﹤0.01% 1703
2020
Q2 		$32.6K Buy
2,644
+169
+7% +$1.91K ﹤0.01% 1448
2020
Q1 		$22.2K Sell
2,475
-108
-4% -$1.11K ﹤0.01% 1495
2019
Q4 		$25.3K Sell
2,583
-333
-11% -$2.97K ﹤0.01% 1631
2019
Q3 		$20.1K Sell
2,916
-626
-18% -$4.8K ﹤0.01% 1656
2019
Q2 		$32.7K Sell
3,542
-1,515
-30% -$18.3K ﹤0.01% 1459
2019
Q1 		$79.3K Buy
5,057
+341
+7% +$6.01K 0.01% 982
2018
Q4 		$72.7K Buy
4,716
+351
+8% +$7.2K 0.01% 861
2018
Q3 		$94K Buy
4,365
+1,350
+45% +$31.3K 0.01% 855
2018
Q2 		$73.3K Buy
3,015
+1,238
+70% +$25.2K 0.01% 934
2018
Q1 		$30.4K Sell
1,777
-3,385
-66% -$66.1K ﹤0.01% 1217
2017
Q4 		$97.8K Buy
+5,162
New +$77.7K 0.02% 738

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return

American Portfolios Advisors's TEVA Position: Q3 2022 in Review

American Portfolios Advisors reduced its Teva Pharmaceuticals (TEVA) stake by 24% in Q3 2022, selling an estimated $4.25K and leaving 1,500 shares worth $12.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2443.

American Portfolios Advisors first reported a position in TEVA in Q4 2017 and has held it in 20 quarters since. The position peaked at $97.8K in Q4 2017. 430 funds tracked by Wall St. Rank hold TEVA as of Q3 2022.

  • American Portfolios Advisors held 1,500 shares of Teva Pharmaceuticals worth $12.1K as of Q3 2022.
  • American Portfolios Advisors sold 481 Teva Pharmaceuticals shares in Q3 2022, an estimated $4.25K.
  • Teva Pharmaceuticals made up ﹤0.01% of American Portfolios Advisors's portfolio in Q3 2022, its #2443 holding.
  • American Portfolios Advisors first reported a position in Teva Pharmaceuticals in Q4 2017 and has held it in 20 quarters since.
  • American Portfolios Advisors's Teva Pharmaceuticals position peaked at $97.8K in Q4 2017.
  • 430 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2022.

Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.